Lentiviral mediated gene delivery as an effective therapeutic approach for Parkinson disease

Continual strategies to devise a complete therapeutic cure for neurodegenerative conditions has been a challenge, majorly due to the presence of blood brain barrier. Lack of targeted delivery in order to minimize loss of dopamine (DA) neurones has been a major challenge to overcome anomalies in Parkinson Disease (PD). PD is a neuromotor degenerative disorder deteriorating motor coordination in affected individuals. Recent research has highlighted the use of lentiviral vectors (LVs) for selective delivery of neuroprotective substance for complete halt of disease progression in PD. LVs have the ability to infect both dividing and non-dividing cells along with non-encoding capability of viral protein that might elicit an immune response. This review will mainly focus on understanding the basic mechanism of action of LVs and its therapeutic aid in PD.

Automated summary

Developing a complete therapeutic cure for neurodegenerative conditions remains a challenge due to the blood brain barrier. Parkinson Disease is a neuromotor degenerative disorder affecting motor coordination, and recent research has highlighted the potential use of lentiviral vectors for targeted delivery of neuroprotective substances.